Schedule of Investments (unaudited)	iShares® MSCI Switzerland ETF
May 31, 2022	(Percentages shown are based on Net Assets)

Security	Shares		Value
Common Stocks
Biotechnology — 0.3%
Bachem Holding AG		65,954	$	5,183,897
Building Products — 1.5%
Geberit AG, Registered		39,775		21,840,312
Capital Markets — 8.6%
Credit Suisse Group AG, Registered		2,961,746		20,754,080
Julius Baer Group Ltd.		270,486		13,969,383
Partners Group Holding AG		24,577		26,444,332
UBS Group AG, Registered		3,576,256		67,443,468
				128,611,263
Chemicals — 6.2%
Clariant AG, Registered		353,357		6,772,848
EMS-Chemie Holding AG, Registered		10,068		8,642,530
Givaudan SA, Registered		9,685		35,626,769
Sika AG, Registered		151,029		41,923,938
				92,966,085
Construction Materials — 1.9%
Holcim AG		591,901		29,347,459
Diversified Telecommunication Services — 1.2%
Swisscom AG, Registered		29,836		17,644,239
Electrical Equipment — 3.4%
ABB Ltd., Registered		1,681,803		51,857,575
Food Products — 22.6%
Barry Callebaut AG, Registered		4,682		10,282,003
Chocoladefabriken Lindt & Spruengli AG, Participation Certificates, NVS		1,313		13,208,504
Chocoladefabriken Lindt & Spruengli AG, Registered		131		13,575,271
Nestle SA, Registered		2,476,128		302,873,059
				339,938,837
Health Care Equipment & Supplies — 5.1%
Alcon Inc.		521,097		39,103,421
Sonova Holding AG, Registered		60,409		21,404,418
Straumann Holding AG		130,544		16,654,341
				77,162,180
Insurance — 8.2%
Baloise Holding AG, Registered		60,191		10,246,824
Swiss Life Holding AG, Registered		35,356		20,048,121
Swiss Re AG		324,734		26,778,836
Zurich Insurance Group AG		143,704		65,812,752
				122,886,533
Life Sciences Tools & Services — 3.1%
Lonza Group AG, Registered		76,963		46,401,425
Machinery — 1.9%
Schindler Holding AG, Participation Certificates, NVS		53,410		10,988,384
Schindler Holding AG, Registered		36,692		7,363,139
VAT Group AG(a)		35,695		10,626,257
				28,977,780

Security	Shares		Value
Marine — 1.1%
Kuehne + Nagel International AG, Registered		62,943	$	16,645,133
Pharmaceuticals — 25.1%
Novartis AG, Registered		1,790,340		162,634,101
Roche Holding AG, NVS		590,802		201,339,964
Roche Holding AG, Bearer		6,058		2,367,905
Vifor Pharma AG (b)		62,292		10,867,980
				377,209,950
Professional Services — 1.8%
Adecco Group AG, Registered		229,375		8,941,801
SGS SA, Registered		7,255		18,039,680
				26,981,481
Real Estate Management & Development — 0.7%
Swiss Prime Site AG, Registered		100,407		10,110,666
Software — 0.6%
Temenos AG, Registered		87,642		8,515,083
Technology Hardware, Storage & Peripherals — 0.9%
Logitech International SA, Registered		212,722		13,012,206
Textiles, Apparel & Luxury Goods — 4.9%
Cie. Financiere Richemont SA, Class A, Registered		530,178		59,003,614
Swatch Group AG (The), Bearer		38,957		10,030,700
Swatch Group AG (The), Registered		108,034		5,263,477
				74,297,791
Total Common Stocks — 99.1%
(Cost: $1,433,041,796)				1,489,589,895
Short-Term Securities
Money Market Funds — 0.0%
BlackRock Cash Funds: Treasury, SL Agency Shares, 0.72%(c)(d)		620,000		620,000
Total Short-Term Securities — 0.0%
(Cost: $620,000)				620,000
Total Investments in Securities — 99.1%
(Cost: $1,433,661,796)				1,490,209,895
Other Assets Less Liabilities — 0.9%				13,232,339
Net Assets — 100.0%			$	1,503,442,234

^(a) Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors.

^(b) Non-income producing security.

^(c) Affiliate of the Fund.

^(d) Annualized 7-day yield as of period end.

1

Schedule of Investments (unaudited) (continued)	iShares® MSCI Switzerland ETF
May 31, 2022

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the period ended May 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

Affiliated Issuer	Value at 08/31/21		Purchases at Cost		Proceeds from Sale			Net Realized Gain (Loss)		Change in Unrealized Appreciation (Depreciation)		Value at 05/31/22		Shares Held at 05/31/22	Income		Capital Gain Distributions from Underlying Funds
BlackRock Cash Funds: Treasury, SL Agency Shares	$	730,000	$	—	$	(110,000	)(a)	$	—	$	—	$	620,000	620,000	$	456	$	—

^(a) Represents net amount purchased (sold).

Derivative Financial Instruments Outstanding as of Period End

Futures Contracts

Description	Number of Contracts		Expiration Date	Notional Amount (000)		Value/ Unrealized Appreciation (Depreciation)
Long Contracts
Swiss Market Index		115	06/17/22	$	13,491	$	(701,498	)

Fair Value Measurements

Various inputs are used in determining the fair value of financial instruments. These inputs to valuation techniques are categorized into a fair value hierarchy consisting of three broad levels for financial reporting purposes as follows: 

• Level 1 – Unadjusted price quotations in active markets/exchanges for identical assets or liabilities that each Fund has the ability to access;

• Level 2 – Other observable inputs (including, but not limited to, quoted prices for similar assets or liabilities in markets that are active, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the assets or liabilities (such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks and default rates) or other market-corroborated inputs); and

• Level 3 – Unobservable inputs based on the best information available in the circumstances, to the extent observable inputs are not available (including the BlackRock Global Valuation Methodologies Committee’s (the “Global Valuation Committee’s”) assumptions used in determining the fair value of financial instruments).

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the fair value hierarchy classification is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Investments classified within Level 3 have significant unobservable inputs used by the Global Valuation Committee in determining the price for Fair Valued Investments. Level 3 investments include equity or debt issued by privately held companies or funds. There may not be a secondary market, and/or there are a limited number of investors. The categorization of a value determined for financial instruments is based on the pricing transparency of the financial instruments and is not necessarily an indication of the risks associated with investing in those securities. For information about the Fund’s policy regarding valuation of financial instruments, refer to its most recent financial statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

2

Schedule of Investments (unaudited) (continued)	iShares® MSCI Switzerland ETF
May 31, 2022

Fair Value Measurements (continued)

	Level 1		Level 2			Level 3		Total
Investments
Assets
Common Stocks	$	24,443,251	$	1,465,146,644		$	—	$	1,489,589,895
Money Market Funds		620,000		—			—		620,000
	$	25,063,251	$	1,465,146,644		$	—	$	1,490,209,895
Derivative financial instruments(a)
Liabilities
Futures Contracts	$	—	$	(701,498	)	$	—	$	(701,498	)

^(a) Derivative financial instruments are futures contracts. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument.

Portfolio Abbreviations - Equity

NVS Non-Voting Shares

3